Drug Trial Radar · NCT03347279
Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma
Last checked: Nov 20, 2026Latest source record: Nov 26, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,061
Actual
Start
Nov 23, 2017
Primary completion
Sep 8, 2020
Study completion Nov 12, 2020
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Amgen
- First posted
- Nov 20, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma
Conditions
- Asthma
Interventions
Experimental: TezepelumabBiological
Tezepelumab subcutaneous injection
PlaceboOther
Placebo subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annual Asthma Exacerbation Rate in Adult and Adolescent Patients With Uncontrolled AsthmaTime frame: From randomisation to Study Week 52.
- Annual Asthma Exacerbation Rate in Adult and Adolescent Patients With Uncontrolled Asthma in Subjects With Baseline Eosinophils < 300 Cells/uLTime frame: From randomisation to Study Week 52.
Locations
289 sites in 18 countries. Site status is shown where the registry gives one.
Research Site
Dothan, Alabama
Research Site
Foley, Alabama
Research Site
Gilbert, Arizona
Research Site
Tucson, Arizona
Research Site
Bakersfield, California
Research Site
Encinitas, California
Research Site
Huntington Beach, California
Research Site
Long Beach, California
Research Site
Los Angeles, California
Research Site
Mission Viejo, California
Research Site
Newport Beach, California
Research Site
Northridge, California
Research Site
Palm Desert, California
Research Site
Rolling Hills Estates, California
Research Site
Walnut Creek, California
Research Site
Westminster, California
Research Site
Denver, Colorado
Research Site
New Haven, Connecticut
Research Site
Celebration, Florida
Research Site
Kissimmee, Florida
Research Site
Kissimmee, Florida
Research Site
Orlando, Florida
Research Site
Orlando, Florida
Research Site
Panama City, Florida
Research Site
Port Charlotte, Florida
Research Site
Sarasota, Florida
Research Site
Sebring, Florida
Research Site
St. Petersburg, Florida
Research Site
St. Petersburg, Florida
Research Site
St. Petersburg, Florida
Research Site
Tampa, Florida
Research Site
Winter Park, Florida
Research Site
Fayetteville, Georgia
Research Site
Gainesville, Georgia
Research Site
Savannah, Georgia
Research Site
Stockbridge, Georgia
Research Site
Boise, Idaho
Research Site
Michigan City, Indiana
Research Site
Fort Mitchell, Kentucky
Research Site
Louisville, Kentucky
Showing 40 of 289 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.